Stock Events

Stock Events

HCW Biologics 

$0.27
21
-$0.03-10.7% Thursday 20:00

Statistics

Day High
0.29
Day Low
0.25
52W High
17.8
52W Low
0.25
Volume
772,966
Avg. Volume
8,299,480
Mkt Cap
723,865.8
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
-6.79
-3.33
0.14
3.6
Expected EPS
-0.44
Actual EPS
N/A

Financials

-1,169.61%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
5.13MRevenue
-60.05MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HCWB. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap10.61B
Moderna is a leader in mRNA technology, directly competing in the biotech space for developing innovative therapies, similar to HCW Biologics' focus on novel treatments.
BioNTech
BNTX
Mkt Cap24.99B
BioNTech competes in the biopharmaceutical field, focusing on personalized medicine and vaccines, overlapping with HCW Biologics' therapeutic development.
Novavax
NVAX
Mkt Cap1.36B
Novavax is involved in the development of vaccines for infectious diseases, competing with HCW Biologics in the broader biotech and vaccine market.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a large pharmaceutical company with a wide range of products, including biologics, making it a competitor in the healthcare and biotech industry.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical division Janssen, competes in the development of innovative treatments, including biologics, which is HCW Biologics' focus.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that focuses on antiviral drugs and other treatments, competing with HCW Biologics in the biotech space.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotechnology firm specializing in human therapeutics, with a product range that competes with HCW Biologics' therapeutic development efforts.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals is known for its innovative biologic medicines, directly competing with HCW Biologics in the field of biopharmaceuticals.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals focuses on creating new possibilities in medicine to cure diseases and improve people's lives, competing with HCW Biologics in the biotech innovation sector.

About

HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida.
Show more...
CEO
Dr. Hing C. Wong Ph.D.
Employees
36
Country
US
ISIN
US40423R2040

Listings

XNAS
US
HCWB
BOATS
BOATS
HCWB.BOATS

0 Comments

Share your thoughts

FAQ

What is HCW Biologics stock price today?▼
The current price of HCWB is $0.27 USD — it has decreased by -10.7% in the past 24 hours. Watch HCW Biologics stock price performance more closely on the chart.
What is HCW Biologics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange HCW Biologics stocks are traded under the ticker HCWB.
Is HCW Biologics stock price growing?▼
HCWB stock has fallen by -32.84% compared to the previous week, the month change is a -57.47% fall, over the last year HCW Biologics has showed a +17.91% increase.
What is HCW Biologics market cap?▼
Today HCW Biologics has the market capitalization of 723,865.8
When is the next HCW Biologics earnings date?▼
HCW Biologics is going to release the next earnings report on May 07, 2026.
What were HCW Biologics earnings last quarter?▼
HCWB earnings for the last quarter are -4.13 USD per share, whereas the estimation was 1.58 USD resulting in a -361.39% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is HCW Biologics revenue for the last year?▼
HCW Biologics revenue for the last year amounts to 5.13M USD.
What is HCW Biologics net income for the last year?▼
HCWB net income for the last year is -60.05M USD.
How many employees does HCW Biologics have?▼
As of April 05, 2026, the company has 36 employees.
In which sector is HCW Biologics located?▼
HCW Biologics operates in the Health Care sector.
When did HCW Biologics complete a stock split?▼
The last stock split for HCW Biologics was on April 11, 2025 with a ratio of 1:40.
Where is HCW Biologics headquartered?▼
HCW Biologics is headquartered in Miramar, US.